Literature DB >> 4122324

Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides.

D E McFarlin, S E Blank, R F Kibler, S McKneally, R Shapira.   

Abstract

Lewis rats were used to determine the encephalitogenic activity of myelin basic protein of different species and of 45-residue fragments of basic protein. Basic protein from guinea pigs was more active than that from rats, and the fragments from the two species showed the same order of activity. Bovine basic protein was the least active of the intact proteins, and the respective fragment was inactive. Studies of serum-binding capacity did not support the hypothesis that blocking antibody played a role in this biological variation, whereas consideration of the amino acid sequences of the three fragments suggested that differences in primary structure, operating either at the sensitization or the effector phase of the immune response, could account for the variation.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4122324     DOI: 10.1126/science.179.4072.478

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  22 in total

Review 1.  Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination.

Authors:  A W Lohse; I R Cohen
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Species-specificity and localization of encephalitogenic sites in myelin basic protein.

Authors:  M W Kies
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

Authors:  R R Bartlett; M Dimitrijevic; T Mattar; T Zielinski; T Germann; E Rüde; G H Thoenes; C C Küchle; H U Schorlemmer; E Bremer
Journal:  Agents Actions       Date:  1991-01

4.  Reactivity of neuro-antigen-sensitized lymphocytes against syngeneic, allogeneic and tolerated allogeneic neural tissue.

Authors:  J Cunningham; P McCullagh
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

Review 5.  Antigen-specific therapies for the treatment of autoimmune diseases.

Authors:  D A Hafler; H L Weiner
Journal:  Springer Semin Immunopathol       Date:  1995

Review 6.  Effects of leflunomide on immune responses and models of inflammation.

Authors:  R R Bartlett; H Anagnostopulos; T Zielinski; T Mattar; R Schleyerbach
Journal:  Springer Semin Immunopathol       Date:  1993

7.  Susceptibility to experimental allergic encephalomyelitis in two strains of rats and their hybrids.

Authors:  J Lindh
Journal:  Acta Neuropathol       Date:  1977-04-29       Impact factor: 17.088

8.  Delayed-type hypersensitivity to myelin basic proteins in mice susceptible to allergic encephalomyelitis.

Authors:  D S Linthicum; G A Hashim
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

9.  Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides.

Authors:  H Kasahara; M Itoh; T Sugiyama; N Kido; H Hayashi; H Saito; S Tsukita; N Kato
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Delayed neuropathology after carbon monoxide poisoning is immune-mediated.

Authors:  Stephen R Thom; Veena M Bhopale; Donald Fisher; Jie Zhang; Phyllis Gimotty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.